Carcinogen bioassay involves the exposure of laboratory animals to one or more levels of the test substance and an evaluation of the tumor occurrence rates in the treated groups relative to those in the unexposed controls. The historical control groups obtained from other similar studies also provid
On Testing for a Change-Point in Variance of Normal Distribution
โ Scribed by M. Ishaq Bhatti; Jinglong Wang
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 109 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0323-3847
No coin nor oath required. For personal study only.
โฆ Synopsis
This paper addresses the problem of testing for a change about the variance of sequence of normal random variables with unknown means. It compares the power performance of five tests, namely: L-test based on Lehmann's (1951) U-statistic, B-test based on bayesian method, R-test derived from likelihood method, C-test based on Brown et al.'s (1975) CUSUM of squares method and finally, the LM-test based on Nyblom's (1989) and Hansen's (1991) Lagrange multiplier method. An empirical power comparison of the five tests suggests that none of the tests power lead to another. However, it is observed that when change-point is between the beginning and the mid portion, the L and R test are better and when the change-point is between the mid portion and the end, CUSUM of square and the B test are better as compared to the other tests.
๐ SIMILAR VOLUMES
Testing for a change in the slope of the simple linear regression model has many applications in biosciences, quality control and survival analysis. This paper compares Anderson-Darling and Erdo ยดs-Darling type test statistics which are based on the least squares change point process of Sen (1980) w
Dementia is characterized by accelerated cognitive decline before and after diagnosis as compared to normal ageing. Determining the time at which that rate of decline begins to accelerate in persons who will develop dementia is important both in describing the natural history of the disease process